Oxford Science Enterprises Plc - Net Worth and Insider Trading
Oxford Science Enterprises Plc Net Worth
The estimated net worth of Oxford Science Enterprises Plc is at least $55 Million dollars as of 2024-09-20. Oxford Science Enterprises Plc is the 10% Owner of PepGen Inc and owns about 4,755,388 shares of PepGen Inc (PEPG) stock worth over $44 Million. Oxford Science Enterprises Plc is also the 10% Owner of Barinthus Biotherapeutics PLC and owns about 8,797,770 shares of Barinthus Biotherapeutics PLC (BRNS) stock worth over $11 Million. Details can be seen in Oxford Science Enterprises Plc's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Oxford Science Enterprises Plc has not made any transactions after 2022-05-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Oxford Science Enterprises Plc
Oxford Science Enterprises Plc Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Oxford Science Enterprises Plc owns 2 companies in total, including Barinthus Biotherapeutics PLC (BRNS) , and PepGen Inc (PEPG) .
Click here to see the complete history of Oxford Science Enterprises Plc’s form 4 insider trades.
Insider Ownership Summary of Oxford Science Enterprises Plc
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BRNS | Barinthus Biotherapeutics PLC | 2021-05-04 | 10 percent owner |
| PEPG | PepGen Inc | 2022-05-10 | 10 percent owner |
Oxford Science Enterprises Plc Latest Holdings Summary
Oxford Science Enterprises Plc currently owns a total of 2 stocks. Among these stocks, Oxford Science Enterprises Plc owns 4,755,388 shares of PepGen Inc (PEPG) as of May 10, 2022, with a value of $44 Million and a weighting of 80.47%. Oxford Science Enterprises Plc also owns 8,797,770 shares of Barinthus Biotherapeutics PLC (BRNS) as of May 4, 2021, with a value of $11 Million and a weighting of 19.53%.
Latest Holdings of Oxford Science Enterprises Plc
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PEPG | PepGen Inc | 2022-05-10 | 4,755,388 | 9.34 | 44,415,324 |
| BRNS | Barinthus Biotherapeutics PLC | 2021-05-04 | 8,797,770 | 1.23 | 10,777,268 |
Holding Weightings of Oxford Science Enterprises Plc
Oxford Science Enterprises Plc Form 4 Trading Tracker
According to the SEC Form 4 filings, Oxford Science Enterprises Plc has made a total of 1 transactions in PepGen Inc (PEPG) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in PepGen Inc is the acquisition of 879,970 shares on May 10, 2022, which cost Oxford Science Enterprises Plc around $11 Million.
According to the SEC Form 4 filings, Oxford Science Enterprises Plc has made a total of 1 transactions in Barinthus Biotherapeutics PLC (BRNS) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Barinthus Biotherapeutics PLC is the acquisition of 600,000 shares on May 4, 2021, which cost Oxford Science Enterprises Plc around $10 Million.
Insider Trading History of Oxford Science Enterprises Plc
- 1
Oxford Science Enterprises Plc Trading Performance
GuruFocus tracks the stock performance after each of Oxford Science Enterprises Plc's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Oxford Science Enterprises Plc is 6.63%. GuruFocus also compares Oxford Science Enterprises Plc's trading performance to market benchmark return within the same time period. The performance of stocks bought by Oxford Science Enterprises Plc within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Oxford Science Enterprises Plc's insider trading performs compared to the benchmark.
Performance of Oxford Science Enterprises Plc
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 1.75 | | | | | |
| Relative Return to S&P 500(%) | 2.21 | | | | | |
Oxford Science Enterprises Plc Ownership Network
Oxford Science Enterprises Plc Owned Company Details
What does Barinthus Biotherapeutics PLC do?
Who are the key executives at Barinthus Biotherapeutics PLC?
Oxford Science Enterprises Plc is the 10 percent owner of Barinthus Biotherapeutics PLC. Other key executives at Barinthus Biotherapeutics PLC include director & Chief Executive Officer William Enright , Chief Scientific Officer Nadege Pelletier , and Chief Financial Officer Gemma Brown .
Barinthus Biotherapeutics PLC (BRNS) Insider Trades Summary
Over the past 18 months, Oxford Science Enterprises Plc made no insider transaction in Barinthus Biotherapeutics PLC (BRNS). Other recent insider transactions involving Barinthus Biotherapeutics PLC (BRNS) include a net sale of 15,000 shares made by William Enright , a net purchase of 13,750 shares made by Robin Wright , and a net purchase of 10,000 shares made by Joseph Scheeren .
In summary, during the past 3 months, insiders sold 0 shares of Barinthus Biotherapeutics PLC (BRNS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 15,000 shares of Barinthus Biotherapeutics PLC (BRNS) were sold and 23,750 shares were bought by its insiders, resulting in a net purchase of 8,750 shares.
Barinthus Biotherapeutics PLC (BRNS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Barinthus Biotherapeutics PLC Insider Transactions
Oxford Science Enterprises Plc Mailing Address
Above is the net worth, insider trading, and ownership report for Oxford Science Enterprises Plc. You might contact Oxford Science Enterprises Plc via mailing address: 46 Woodstock Road, Oxford X0 Ox2 6ht.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
